European Manufacturers of Veterinary Diagnostics EMVD Association Européenne des Fabricants de Réactifs Vétérinaires AEFRV Presentation on the activities.

Slides:



Advertisements
Similar presentations
European Economic and Social Committee Consultative Committee on Industrial Change "CCMI" P r e s e n t a t i o n of J á n o s T Ó T H Member of the EESC.
Advertisements

Implications for the Regions EU-Regional Policy 1 Governance White Paper Introduction Adoption of White Paper on European Governance, July 25, 2001 Aim:
0 1 Mirrorgroup Animal Health Dutch experiences 2 Trigger, initiative and chair Initiative: CVO European trigger: request Executive Board of ETPGAH to.
European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires IAEA Consultants Meeting on.
Merton V. Smith, Ph.D., J.D. Director International Programs Center for Veterinary Medicine U.S. Food and Drug Administration Governance of Veterinary.
Bled 04/09/2004 Annual Report of the European Regional Focal Point. Dominique PLANCHENAULT.
XBRL AND BANKING SUPERVISION José María Roldán Director General of Regulation, Banco de España Chair, XBRL España Chair, Committee of European Banking.
GLOBAL REGULATORY STRATEGY CONSIDERATIONS SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES SEPTEMBER 14-17, 2008 BOSTON, MA.
1 Facilitating Commercialisation and Market Deployment of Environmentally Sound, Sustainable and Cost-competitive Bioenergy Technologies………
European Parliament Advanced Therapies Hearing May 11, 2006 Advanced Therapies The proposed EU regulation from the viewpoint of a Pharmaceutical company.
Challenges and the benefits of interoperability for the railway industry and the rail transport Eric Fontanel UNIFE General Manager.
European Women ’ s Lobby Lobby Europ é en Des Femmes.
Harmonisation, Standardisation and approval of diagnostic kits Manufacturers point of view on validation of veterinary diagnostics – Seeking an efficient.
Critical Role of ICT in Parliament Fulfill legislative, oversight, and representative responsibilities Achieve the goals of transparency, openness, accessibility,
1 Progress report: DISCONTOOLS Project Morgane Delavergne DISCONTOOLS Project Manager, September 22nd, 2009 Mirror Group Meeting Châtelain Hotel, Brussels.
1 OECD Mission and Overview. 2 3 What is the OECD? An Organisation of 30 member countries committed to democracy and the market economy A provider of.
Conformity Assessment and Accreditation Mike Peet Chief Executive Officer South African National Accreditation System.
Cultural Heritage and Global Change: a new challenge for Europe Working for strengthening the European Research Area Towards Joint Programming in Research.
1 Case Study Innovative Medicines Initiative (IMI) Karen Strandgaard EFPIA EuroConference, Brussels April 26th, 2006.
Presentation by Lia van Ginneken – EMP Secretary & João Salazar – EMP Chairman 21st February 2009.
Aid for Trade Needs Assessment Ukraine: Trade and Human Development Igor Burakovsky, Institute for Economic Research and Policy Consulting (Ukraine) 14.
Le Prix IST: Objectifs et conditions de participation Georges Grunberg (EURO-CASE- Academie des technologies)
How the EU is financed EU spends around €140 billion euro per year across the Member States All Member States contribute to the EU budget In 2011, Ireland’s.
The concept for a network of national Reference Laboratories for high risk IVDs – Results of the working group meeting 1.
1 18 March 2010AGNA meeting EASAC update Yves Morier.
European Commission, Technical Assistance Information Exchange Unit (TAIEX), DG Enlargement in co-operation with The Bulgarian Chamber of Commerce and.
European Commission Introduction to the Community Programme for Employment and Social Solidarity PROGRESS
1 SMEs – a priority for FP6 Barend Verachtert DG Research Unit B3 - Research and SMEs.
1 OIE Global Conference on Veterinary Education and the role of Veterinary Statutory Body 4 – 6 December 2013 Foz do Iguazu (Brazil)
A Strategic Research Agenda for Europe in the field of illicit drugs Priorities for socio-economic and humanities research HDG Brussels - December 10,
Towards an Industry Advisory Group An Open Round-Table Conversation 19 May 2009 Do not copy or reproduce without express written permission of Foresight.
IFAP presentation. WHAT IS IFAP? IFAP is the world farmers organisation representing > 600 million farm families A global network in which farmers from.
IRG/ERG Gabrielle Gauthey Member of the Board of ART.
“The Quality Infrastructure in Lebanon” Export Norms, Quality Control and Competitiveness FUTURE PROGRAMME Prepared By Ali Berro Director of Quality Programme.
Tom Introduction to international standards and standardisation processes Carina Svensson, Programme Manager – Swedish Standards Institute (SIS)
16-17 November 2005 COSCAP – NA Project Steering Group Guangzhou, China 1 Co-operating with the European Aviation safety Agency.
DISCONTOOLS “Disease Control Tools” Telmo Valinhas Project Manager CNA – Mirror Groups Meeting, February 27th, 2008.
1 DISCONTOOLS Activities Update Morgane Delavergne – DISCONTOOLS Project Manager 2 nd December 2008 ETPGAH Mirror Groups meeting – Hotel Châtelain, Brussels.
INTERNATIONAL ELECTROTECHNICAL COMMISSION Standardization Management Board Decisions How They Affect Your TAG! Jim Matthews Vice President & SMB Chairman.
Slide 1 ROAD TO EUROPE – PROGRAM OF ACCOUNTING REPORTING AND INSTITUTIONAL STRENGTHENING How can the European Federation of Accountants (FEE) Assist ?
Project funded by the Spanish Ministry of Science and Innovation and the European Regional Development Fund PROGRESS REPORT SEPTEMBER 2009 Brussels, 22.
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
Future needs for capacity building and recommendations to the OIE Dr Sarah Kahn Consultant to the OIE
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
VICH General Principles and current update of VICH Outreach Forum activity 1.
VICH Training Strategy Steven D. Vaughn, DVM Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine U.S. Food and Drug Administration.
Industry: trends, concerns hopes and ideas VICH5 Conference Carel du Marchie Sarvaas, Executive Director October 2015.
1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.
PAHO has created a mechanism in order that the countries that do not have aptitude to guarantee generic insurances accede to them in an immediate.
Workshop on “EU Enlargement: Regulatory Convergence in Non-acceding Countries” Athens 7 – 8 November 2003 Regulatory Convergence and Technical Standards.
BioEnergy Sustaining The Future 2 BESTF2 Briefing Event 11 th December 2013 Dr Megan Cooper, BESTF co-ordinator.
1 THE OIE REPORT 32 nd VICH SC Meeting / 6 th VICH Outreach Forum Meeting Jean-Pierre Orand, Anses, France, OIE Collaborating Centre.
Coordination committee meeting – 01/10/2008 Presented by: John Lougheed European Network for Rural Development : Legal framework and structures.
Waiving TABST for vaccines Argentina: Not an allowed procedure today Require batch safety tests in laboratory animals, repeated by authorities Currently.
1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating.
MicroQLab (Training in innovation through the Quality System in Food Microbiological Laboratories) Amparo de Benito 1, Chiara.
HIMSS Standards Activities
HIMSS STANDARDS INITIATIVES
Session 2 European Regulatory Environment (just a part!)
The Sixth Strategic Plan: Camels Concerned
EU Reference Centres for Animal Welfare
European Regulatory Environment (just a part!)
Representation for the Americas
Standardization Management Board Decisions How They Affect Your TAG!
Organisation Mondiale de la Santé Animale
EPAN – DG Troika secretariat Directors and Experts of Better Regulation Luxembourg,7th January 2005.
Dr Manisha Shridhar Regional Advisor WHO-SEARO
First Meeting of Mirror Groups
Representation for the Americas
National Platforms meeting
Presentation transcript:

European Manufacturers of Veterinary Diagnostics EMVD Association Européenne des Fabricants de Réactifs Vétérinaires AEFRV Presentation on the activities of the EMVD Johanna Koolen

Association Européenne des Fabricants de Réactifs Vétérinaires EMVD (former AEFRV)  History  Members  Aim  Priorities: Harmonization of Regulations Harmonization and OIE procedure Unfair competition of Public Laboratories Reference panels European affairs: ETPGAH participation  Conclusion European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires AEFRV / EMVD History  The Association in its current form (an association under the French associative law of 1901) was created in 2005 with the goal to defend the interests of veterinary diagnostics producers  The major subjects: the harmonization of the complicated European Regulatory situation for veterinary diagnostics the unfair competitive position of some public laboratories (producers of diagnostics and evaluators of the quality of our commercial kits, resulting in a judge and jury situation) The active collaboration with the OIE to make their new registration procedure for veterinary diagnostics more interesting as a marketing tool (for manufacturers), with the ultimate goal to have an acceptable procedure for governments having their own registration procedure (become actors of harmonization) European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires EMVD Members  Applied Biosystems  Agrolabo, Italy  Bio-X Diagnostics, Belgium  IDEXX Europe, Netherlands  INGENASA, Spain  Institut Pourquier, France  MegaCor, Germany  Prionics, Netherlands  Svanova, Sweden  SYNBIOTICS Europe, France European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires Members of the Board  Chair: Johanna Koolen - Applied Biosystems  Secretary: Annita Ginter - Bio-X Diagnostics  Treasurer: François Merit - IDEXX  Vice Chair: Liesbeth Jacobs – Prionics  Vice Chair: Malik Merza – Svanova  Vice Chair: Serge Leterme – IDEXX  Secretariat: SIMV France (meeting rooms, Web site creation & updating, administrative actions) European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires Veterinary Diagnostics….  Are an excellent tool to control disease….  However technically the same, very different from human diagnostics:  Pricing: Tests are cheaper, they have a direct influence on the meat price  “Patients” are divided into different species  Different regulations apply  Technically the same but different from food safety and environmental testing: Mainly due to a different regulation European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires Aims  Have a representation of the animal health diagnostics industry on a European level. Being a European association provides a legitimacy to defend the interests of the industry  Become an actor instead of a spectator: be a privileged interlocutor and obtain information on regulatory changes that affect our business and European initiatives in general.  Result: the EMVD has representatives in different committees:  Animal Health Advisory Committee AHAC of the general directorate of consumers’ health (DG Sanco) of the European commission  DG Sanco Vaccine task force  The executive board of the European Technology platform for global animal health – ETPGAH  Discontools (ETPGAH) enabling the relay of relevant information to its members  Be a privileged contact for the OIE in their combat to improve animal health European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires  In many countries of the world, Veterinary Diagnostics are actively regulated, having vaccine regulations as a basis. The regulation is therefore (too) stringent and registration laborious. Example: USA; Japan; China  In Europe, some countries like Germany, Spain and some others actively regulate veterinary diagnostic tests, or ty to implement new regulations (France)  There are different coexisting regulations and also norms, that are costly in time and fees Harmonization of existing regulations on Veterinary Diagnostics (1) European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires  Batch control: Many (European) countries have batch control for each batch of product that is commercialized. Batch controls are not recognized between European member states.  Batch control also exists in countries where there is no national registration procedure  As a result the same batch is tested by different reference laboratories, thereby multiplying our costs. Harmonization of existing regulations on Veterinary Diagnostics (2) European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires In May 2005, the OIE registration Procedure was launched:  This registration procedure comes in complement to the existing ones and is very costly (9000 € every 5 years, plus 0.1% of the annual sales as additional tax and is recently revised to 4500€).  Moreover: The procedure itself is long and requiring quite some investment in time and money for “fitness for purpose studies” as asked in the procedure  Most importantly: there is no recognition by other countries having their own registration procedure Harmonization and OIE procedure (1) European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires The OIE registration Procedure is available on the Internet:  We noticed that different authorities copy the requirements of the procedure into their public tenders. This results in an increased number of requirements that we cannot always fulfill.  We proposed to split the real requirements and additional information and keep only the requirements on the Web site. Harmonization and OIE procedure (2) European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires PROPOSAL: The EMVD worked with the OIE to come to a convergence of interests to have the procedure evolve into  A procedure that: Is easier to apply Is less expensive Will be recognized by countries having an active regulation on veterinary diagnostics in the future Has a shorter timeline Harmonization and OIE procedure (3) European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires RESULT:  The procedure : Was simplified Price was lowered from 9000 to 4500 Euros ….  Today the successful registration by OIE does not dispense from registrations in other countries. To be able to create a register of quality diagnostic tests, the recognition is a prerequisite. It therefore stays a marketing tool (for the moment) Harmonisation and OIE procedure (4) European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires  The constitution and use of reference material is crucial for the activity of diagnostics producers  There is no news on this side. It is considered an activity of the OIE reference laboratories, they should provide validated panels that permit to establish standards.  Diagnostic manufacturers are willing to help with the filling of large quantities of reference material – they have the material to perform this task Reference Material European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires ETPGAH European Technology Platform for Global Animal Health Contributions of the EMVD:  Actively involved in the elaboration of the Vision Paper; Strategic Research agenda (SRA) and Action Plan  The EMVD is present in the executive board of the ETPGAH since 2006  The main conclusions were to continue developing the action items through a new network, called DISCONTOOLS and the creation of national mirror groups European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires ETPGAH / Discontools / Mirror Groups  EMVD members are taking part in the different DICONTOOLS work groups of experts, working on priorization of diseases, gap analyses (availability of products, gaps in regulation, gaps in knowledge), new technologies (speed up time lapse between invention and innovation)…  EMVD members are encouraged to participate actively in the national mirror groups that have been created all over Europe European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires Competition of Public Laboratories (1)  Diagnostics producers undergo harsh competition from public laboratories whose primary goal is to provide surveillance to animal health, by acting as an independent reference laboratory for national governments. Some of them are also OIE reference laboratories.  Their expertise is highly appreciated and some perform research on a high level  However, some public laboratories produce veterinary diagnostics and commercialise them or commercialize their services with home brew diagnostics. European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires Competition of Public Laboratories (2)  Some public laboratories block the market, as their method or test is the only one authorized (despite of the existence of better tests or methods)  We feel that a diagnostics producing public laboratory cannot objectively evaluate commercial tests  Public laboratories do not always adhere to a quality system (ALL EMVD members are at least ISO certified) European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires Competition of Public Laboratories (3)  The EMVD discloses this conflict of interest. This is unfair competition and moreover, it does not promote animal health There is a possibility to present cases, and file complaints to DG Enterprise who can intervene with the commission Action: resume the current unfair competitive situations still present in Europe and submit in a report to DG Enterprise (this consultation is running until December 15) European Manufacturers of Veterinary Diagnostics EMVD

Association Européenne des Fabricants de Réactifs Vétérinaires Conclusions  Harmonization of existing regulation is welcomed: The OIE procedure could play this role if recognized by countries having a national registration  The unfair competitive position of public laboratories should be resolved  Recognition of batch controls is needed between (European) countries  Could this be a role for the OIE reference laboratories? European Manufacturers of Veterinary Diagnostics EMVD